Unilever rules out increasing £50bn bid for GSK unit after backlash
Plan to buy consumer health business has faced fierce opposition from shareholders
Full Article
Unilever rules out increasing £50bn bid for GSK unit after backlash
FT.com
0 shares
2 views
You might like
Related news coverage
Unilever says it will not raise £50bn bid for GSK unit
FT.com
Plan to buy consumer health business faced fierce opposition from shareholders